Several RSV vaccines are being developed. Pfizer's vaccine is already at a place where it will be submitted to the FDA for review in coming months. There are also three monoclonal antibodies under development. One of which I think is also on track to be approved in the next year or two.
A respiratory virus called RSV has a lot of kids in critical condition and hospitals overwhelmed. Vox public health reporter and epidemiologist Keren Landman explains newfound hope for a vaccine.
This episode was produced by Victoria Chamberlin, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Paul Robert Mounsey, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices